Assessing the Efficacy of Drugs for the Acute Treatment of Migraine: Issues in Clinical Trial Design

ISSN： 1172-7047

Source： CNS Drugs, Vol.16, Iss.3, 2002-01, pp. : 181-196

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacology of Current and Future Drugs for the Acute Treatment of Migraine: A Review and An Update

Current Clinical Pharmacology, Vol. 7, Iss. 1, 2012-02 ,pp. : 66-72

Bentham Science Publishers

Access to resources Recommend Favorite

Efficacy of Zolmitriptan at Early Time-Points for the Acute Treatment of Migraine and Treatment of Recurrence: A Randomised, Placebo-Controlled Trial

By Ryan R.E.J.

CNS Drugs, Vol. 13, Iss. 3, 2000-03 ,pp. : 215-226

Adis International

Access to resources Recommend Favorite

A review of the clinical efficacy and tolerability of almotriptan in acute migraine

By Dodick David W

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 7, 2003-07 ,pp. : 1157-1163

Informa Healthcare

Access to resources Recommend Favorite

A Threshold Regression Mixture Model for Assessing Treatment Efficacy in a Multiple Myeloma Clinical Trial

By Lee Mei-Ling Ting

Journal of Biopharmaceutical Statistics, Vol. 18, Iss. 6, 2008-11 ,pp. : 1136-1149

Taylor & Francis Ltd

Access to resources Recommend Favorite

Sumatriptan: a review of its pharmacokinetics, pharmacodynamics and efficacy in the acute treatment of migraine

By Tfelt-Hansen Peer Hougaard Anders

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 1, 2013-01 ,pp. : 91-103

Informa Healthcare

Access to resources Recommend Favorite